KIERLIN ROBERT A - 3 filing on 2013-08-21

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

KIERLIN ROBERT A

(Last)

(First)

(Middle)

2001 THEURER BOULEVARD

(Street)

WINONA

55987

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
08/21/2013

3. Issuer Name and Ticker or Trading Symbol
Regado Biosciences Inc [ RGDO ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, par value $0.001 per share	22,478	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Series A Preferred Stock, par value $0.001 per share	11/19/2004	⁽¹⁾	Common Stock, par value $0.001 per share	201,785	⁽¹⁾	D
Series B Preferred Stock, par value $0.001 per share	07/27/2005	⁽²⁾	Common Stock, par value $0.001 per share	87,325	⁽²⁾	D
Series B Preferred Stock, par value $0.001 per share	08/12/2005	⁽²⁾	Common Stock, par value $0.001 per share	12,725	⁽²⁾	D
Series C Preferred Stock, par value $0.001 per share	03/15/2007	⁽³⁾	Common Stock, par value $0.001 per share	199,050	⁽³⁾	D
Series D Preferred Stock, par value $0.001 per share	12/17/2009	⁽⁴⁾	Common Stock, par value $0.001 per share	998,004	⁽⁴⁾	D
Series D Preferred Stock, par value $0.001 per share	05/25/2011	⁽⁴⁾	Common Stock, par value $0.001 per share	394,871	⁽⁴⁾	D
Series E Preferred Stock, par value $0.001 per share	12/18/2012	⁽⁵⁾	Common Stock, par value $0.001 per share	344,317	⁽⁵⁾	D
Series E Preferred Stock, par value $0.001 per share	03/22/2013	⁽⁵⁾	Common Stock, par value $0.001 per share	299,401	⁽⁵⁾	D

Explanation of Responses:

1. The shares of Series A Preferred Stock have no expiration date and shall automatically convert upon the consummation of the Issuer's initial public offering at a conversion ratio of 1 share of Series A Preferred Stock to 0.05988024 shares of common stock, for no additional consideration.

2. The shares of Series B Preferred Stock have no expiration date and shall automatically convert upon the consummation of the Issuer's initial public offering at a conversion ratio of 1 share of Series B Preferred Stock to 0.05988024 shares of common stock, for no additional consideration.

3. The shares of Series C Preferred Stock have no expiration date and shall automatically convert upon the consummation of the Issuer's initial public offering at a conversion ratio of 1 share of Series C Preferred Stock to 0.05988024 shares of common stock, for no additional consideration.

4. The shares of Series D Preferred Stock have no expiration date and shall automatically convert upon the consummation of the Issuer's initial public offering at a conversion ratio of 1 share of Series D Preferred Stock to 0.05988024 shares of common stock, for no additional consideration.

5. The shares of Series E Preferred Stock have no expiration date and shall automatically convert upon the consummation of the Issuer's initial public offering at a conversion ratio of 1 share of Series E Preferred Stock to 0.05988024 shares of common stock, for no additional consideration.

Remarks:

	/s/ Robert Kierlin	08/21/2013
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.